
About Morphogene Biotech Private Limited
Data last updated:
Morphogene Biotech Private Limited is a private limited company based in Indore, Madhya Pradesh, India, a subsidiary of Dhanganga Dealcomm Pvt.Ltd. It operates in the agricultural products distribution segment of the agriculture sector. It was incorporated on 09 April 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24233MP2013PTC030485. Its GSTIN is 23AAICM7029A1ZV (Madhya Pradesh). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹2 Cr and a paid-up capital of ₹1.33 Cr. It is led by directors Sanjay Periwal and Karan Kumar Kakkad.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 3rd Floor Babadeep Complex 7/1 Maharani Road, Indore, Madhya Pradesh, India – 452007.
As per the financials filed for FY 2024, the company reported a revenue of ₹22.67 Lakh. For the same year it recorded a net profit of ₹81,071 (net margin 3.6%) and EBITDA of ₹87,182 (EBITDA margin 3.8%). Revenue has grown at a compounded annual rate (CAGR) of 26% over three years and 26% over five years.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website phytobiotech.in.
Company details
Contact details
Morphogene Biotech Private Limited's registered office is in Indore, Madhya Pradesh. Its website is phytobiotech.in. Its e-mail address is in the company report.
- Email
- Website
- Social Media
- Registered Address3rd Floor Babadeep Complex 7/1 Maharani Road, Indore, Madhya Pradesh, India – 452007
- IndustryAgriculture, Agro Retail & Distribution
To see the full contact details of Morphogene Biotech Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Morphogene Biotech is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Morphogene Biotech Private Limited, buy the company report.
Financials of Morphogene Biotech Private Limited
FY 2025 filings availableMorphogene Biotech Private Limited reported revenue of ₹22.67 Lakh for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 26% over five years. EBITDA rose 588% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹87,182 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹81,071 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.8% | ||||
| Net Profit Margin | 3.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Morphogene Biotech Private Limited, buy the company report.
Board of directors of Morphogene Biotech Private Limited
Morphogene Biotech has 2 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sanjay Periwal | Director | 26 Aug 2013 | 13 Years 2 Months | Current |
| Karan Kumar Kakkad Also directs: Pretty Dealtrade Private Limited, Primerose Dealtrade Private Limited, Mahurat Commotrade Private Limited and 3 more | Director | 26 Apr 2018 | 8 Years 6 Months | Current |
Auditor
Morphogene Biotech Private Limited is audited by N PARIK & CO for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| N PARIK & CO | FY 2020 | 020314C |
Shareholding
The shareholding of Morphogene Biotech Private Limited is on record for 5 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2019 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Morphogene Biotech Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Morphogene Biotech Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Morphogene Biotech Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Morphogene Biotech has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AAICM7029A1ZV | Madhya Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Morphogene Biotech Private Limited, buy the company report.
Recent activity
Morphogene Biotech Private Limited has 8 board changes on record since 2013: 2 appointments and 6 cessations. The latest: Rajshree Mohta ceased to be Director on 10 May 2025.
Frequently asked questions
Morphogene Biotech is an active private limited company based in Indore, Madhya Pradesh, India. The company works in agro retail and distribution, within the agriculture industry. It was incorporated on 09 April 2013 (13+ years old) and is registered under CIN U24233MP2013PTC030485.
Morphogene Biotech has 2 current directors:
- Sanjay Periwal - Director
- Karan Kumar Kakkad - Director
The latest financial statements of Morphogene Biotech on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Morphogene Biotech is 23AAICM7029A1ZV, registered in Madhya Pradesh. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Morphogene Biotech is U24233MP2013PTC030485. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Morphogene Biotech was incorporated on 09 April 2013, making it 13+ years old. It is registered with the Registrar of Companies, Gwalior.
Rajshree Mohta ceased to be Director on 10 May 2025. Karan Kumar Kakkad ceased to be Additional Director on 29 Sep 2018. Arun Kumar Mohta ceased to be Director on 26 Apr 2018. Morphogene Biotech has 8 board changes on record in total.
Morphogene Biotech can be reached through the website phytobiotech.in. Its registered office is in Indore, Madhya Pradesh, India.
The registered office of Morphogene Biotech is at 3rd Floor Babadeep Complex 71 Maharani Road, Indore, Madhya Pradesh, India – 452007.
Morphogene Biotech operates in the agriculture industry, in the agro retail and distribution segment.

